The purpose of this study is to better understand how X-linked hypophosphatemia (XLH) affects the body and daily life. Phosphate levels are critical in managin…

X-linked Hypophosphatemia (XLH)

~Estimated

~$10 – $1,125

Novo Nordisk A/SNCT07607600

Phase 1

The Impact of Phosphate Metabolism on Healthy Aging

Determine the association between duration and dose of chronic conventional therapy with Pi and renal (nephrocalcinosis/nephrolithiasis), vascular (endothelial…

HypophosphatemiaRicketsHypercalciuria+2 more

~Estimated

~$10 – $6,250

Yale UniversityNCT03771105

Phase 2

A Prospective, Open-label, Genotype-match Controlled, Multicenter Clinical Trial to Investigate the Efficacy and Safety of Intra-amniotic ER004 as a Prenatal Treatment for Male Subjects With XLHED

This is an open-label, prospective, genotype-match controlled for primary estimand, non randomized, multicenter, international Phase 2 clinical trial designed …

X-Linked Hypohidrotic Ectodermal Dysplasia (XLHED)

~Estimated

~$10 – $6,250

EspeRare FoundationNCT04980638